Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging
Top Cited Papers
Open Access
- 1 March 2026
- journal article
- review article
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (2) , 101719
Abstract
Parkinson's disease (PD) is a complex neurodegenerative disorder that poses significant burden on patients and families. Its exact cause is unknown, resulting in limited effective treatments. Mitochondrial dysfunction, linked to genetics, aging, oxidative stress, and environmental factors, is central to PD. Healthy elderly individuals have a compensatory mitochondrial DNA (mtDNA) mechanism in brain cells, but this mechanism is impaired in PD patients, leading to mtDNA reduction, respiratory chain dysfunction, decreased adenosine triphosphate (ATP) synthesis, and inadequate neuron energy. Aging increases oxidative stress, impairing mitochondrial function. Mitochondrial dysfunction in the dopaminergic neurons of the substantia nigra causes neuronal loss and disease progression. Aging microglia also play a crucial role, with a reduced capacity to clear neurotoxic substances, especially in the substantia nigra. A decrease in triggering receptor expressed on myeloid cells 2 (TREM2) gene expression shifts microglia to a pro-inflammatory phenotype, exacerbating neuroinflammatory responses and protein deposition. Down-regulation of the C-X3-C motif chemokine ligand 1 (CX3CL1)/C-X3-C chemokine receptor 1 (CX3CR1) signaling pathway increases the expression of pro-inflammatory cytokines, accelerating neuronal loss and disease progression. Recent research has identified a new astrocyte aging regulatory mechanism involving the cyclic GMP‒AMP synthase (cGAS)/stimulator of interferon genes (STING) signaling pathway, promoting astrocyte aging and exacerbating dopamine neuronal loss and motor dysfunction. Understanding PD pathogenesis, especially mitochondrial dysfunction, aging, and glial cell changes, is crucial for developing effective treatments.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 138 references indexed in Scilit:
- Neuronal TNFα, Not α‐Syn, Underlies PDD‐Like Disease Progression in IFNβ‐KO MiceAnnals of Neurology, 2021
- Parkinson’s Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature2021
- Mitochondrial disorders of the OXPHOS systemFEBS Letters, 2020
- Microglia in Parkinson’s Disease2019
- Aging and Parkinson's disease: Different sides of the same coin?Movement Disorders, 2017
- Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astrogliaGlia, 2012
- Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposureAnnals of Neurology, 1999
- DJ-1, a Novel Oncogene Which Transforms Mouse NIH3T3 Cells in Cooperation withrasBiochemical and Biophysical Research Communications, 1997
- Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's diseaseAnnals of Neurology, 1991
- Mitochondrial oxidative phosphorylation defects in parkinson's diseaseAnnals of Neurology, 1991